Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue July 2014
 •  What's a Brand Worth?  •  BASF Expands in Shanghai  •  Detergent Ingredients Are Safe Says ACI  •  Sunscreen Innovation Act Is Up for Vote  •  Dollar Tree To Buy Family Dollar
Print

Fuji Chemical Granted Inflammation Patent



Published September 8, 2006
Related Searches: eye patent ink industry
Post a comment
Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.



blog comments powered by Disqus